Tilray's First Harvest And Distribution Of Medical Cannabis In Germany Successfully Completed

Canadian  giant Tilray, Inc. (NASDAQ: TLRY) finalized its first harvest of medical cannabis grown in Germany via its German subsidiary Aphria RX GmbH. 

This is the company’s first medical cannabis harvest under European Good Manufacturing Practices standard at its state-of-the-art 6,000 square-meter indoor grow facility in Neumünster, Germany.

Tilray's harvest of medical cannabis was distributed to pharmacies in Germany on behalf of the German Cannabis Agency under the country’s pharmaceutical and narcotic requirements. This milestone represents Tilray’s strong base and operational experience in Europe.

“Our harvest in Germany represents an important milestone in granting access to high-quality and trustworthy medical cannabis to patients and healthcare professionals in Germany,” Denise Faltischek, Tilray's head of international and chief strategy officer, said. …

Full story available on Benzinga.com

More Tilray's First Harvest And Distribution Of Medical Cannabis In Germany Successfully Completed